Zimmer Biomet Holdings Inc Quick Ratio (ZBH) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Zimmer Biomet Holdings Inc   (NYSE: ZBH)

Zimmer Biomet Holdings Inc 's Quick Ratio

ZBH's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.14 below Zimmer Biomet Holdings Inc average.

Within Medical Equipment & Supplies industry 180 other companies have achieved higher Quick Ratio than Zimmer Biomet Holdings Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 3631, from total ranking in the first quarter 2026 at 4258.

Explain Quick Ratio?
How much Cash & cash equivalents ZBH´s has?
What are ZBH´s Current Liabilities?




ZBH Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change 11.63 % 24.81 % -3.06 % -32.72 % -25.19 %
Y / Y Cash & cash equivalent Change -26.38 % -69.36 % 12.64 % 127.19 % 32.56 %
Quick Ratio MRQ 0.14 0.15 0.19 0.54 0.21
ZBH's Total Ranking # 3631 # 4258 # 2965 # 4070 # 2919
Seq. Current Liabilities Change 5.21 % -6.42 % 27.38 % -10.99 % 17.63 %
Seq. Cash & cash equivalent Change -3.35 % -28.33 % -54.21 % 132.12 % -59.78 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 181
Healthcare Sector # 843
Overall Market # 3624


Quick Ratio Statistics
High Average Low
12.58 1.66 0.08
(Mar 31 2015)   (Dec 31 2021)




Financial Statements
Zimmer Biomet Holdings Inc 's Current Liabilities $ 3,014 Millions Visit ZBH's Balance sheet
Zimmer Biomet Holdings Inc 's Cash & cash equivalent $ 410 Millions Visit ZBH's Balance sheet
Source of ZBH's Sales Visit ZBH's Sales by Geography


Cumulative Zimmer Biomet Holdings Inc 's Quick Ratio

ZBH's Quick Ratio for the trailling 12 Months

ZBH Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -3.26 % -12.7 % -20.37 % -22.61 % -3.42 %
Y / Y Cash & cash equivalent TTM Growth -10.45 % -1.15 % 100.57 % 109.11 % 99.6 %
Quick Ratio TTM 0.24 0.26 0.37 0.36 0.26
Total Ranking TTM # 2555 # 2619 # 1982 # 2300 # 2440
Seq. Current Liabilities TTM Growth 2.85 % 5.44 % -0.92 % -9.97 % -7.2 %
Seq. Cash & cash equivalent TTM Growth -5.13 % -25.1 % 1.77 % 23.84 % 4.72 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q2 2026 to $3,013.50 millions, cumulative Quick Ratio decreased to 0.24 below the Zimmer Biomet Holdings Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Zimmer Biomet Holdings Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 2048.

Explain Quick Ratio?
How much Cash & cash equivalents ZBH´s has?
What are ZBH´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 908
Within the Market # 3631


trailing twelve months Quick Ratio Statistics
High Average Low
2.98 0.62 0.13
(Mar 31 2015)   (Jun 30 2024)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Lakeland Industries Inc   0.37 $ 17.100  Millions$ 45.876  Millions
Femasys Inc   0.37 $ 1.444  Millions$ 3.887  Millions
Docgo Inc   0.37 $ 26.569  Millions$ 72.334  Millions
Sanuwave Health Inc   0.36 $ 9.376  Millions$ 25.723  Millions
Iridex Corp  0.36 $ 4.680  Millions$ 13.173  Millions
Heartsciences Inc   0.34 $ 1.657  Millions$ 4.861  Millions
Cadre Holdings inc   0.29 $ 53.984  Millions$ 187.734  Millions
Cytosorbents Corporation  0.24 $ 4.413  Millions$ 18.320  Millions
U S Physical Therapy Inc  0.23 $ 24.887  Millions$ 109.909  Millions
Accuray Incorporated  0.21 $ 40.623  Millions$ 191.405  Millions
Cerus Corporation  0.21 $ 17.980  Millions$ 85.790  Millions
Tenon Medical Inc   0.20 $ 1.677  Millions$ 8.305  Millions
Bioventus Inc   0.19 $ 29.457  Millions$ 154.471  Millions
Avita Medical Inc   0.19 $ 13.096  Millions$ 68.714  Millions
Bausch and Lomb Corp  0.19 $ 367.000  Millions$ 1,942.000  Millions
Dentsply Sirona Inc   0.18 $ 239.000  Millions$ 1,319.000  Millions
Adm Tronics Unlimited Inc   0.18 $ 0.223  Millions$ 1.235  Millions
Catheter Precision Inc   0.16 $ 1.839  Millions$ 11.166  Millions
Zimmer Biomet Holdings Inc   0.14 $ 410.000  Millions$ 3,013.500  Millions
Nexgel Inc   0.12 $ 1.692  Millions$ 14.440  Millions
Ufp Technologies Inc   0.12 $ 9.045  Millions$ 78.304  Millions
Solventum Corporation  0.11 $ 403.000  Millions$ 3,663.000  Millions
Nakamoto Inc   0.11 $ 19.072  Millions$ 179.474  Millions
Petvivo Holdings Inc   0.10 $ 0.135  Millions$ 1.313  Millions
The Pennant Group Inc   0.10 $ 15.273  Millions$ 152.406  Millions
Non Invasive Monitoring Systems Inc  0.10 $ 0.160  Millions$ 1.607  Millions
Boston Scientific Corporation  0.10 $ 749.000  Millions$ 7,530.000  Millions
Integer Holdings Corporation  0.10 $ 21.375  Millions$ 217.141  Millions
Bellevue Life Sciences Acquisition Corp  0.10 $ 1.500  Millions$ 15.734  Millions
National Vision Holdings Inc   0.09 $ 35.998  Millions$ 383.026  Millions

Date modified: 2026-09-11T09:47:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.